EPHB6 has been reported to be frequently mutated in melanomas (7/79, 8.9%)17, with particularly high incidence in desmoplastic melanomas (17/62, 27.4%)18, although the biological significance of these changes has not been investigated. Here, EPHB6 is linked to melanoma.